Wellcome Trust Case Control Consortium

Home
WTCCC1 WTCCC2 WTCCC3
Information
Overview WTCCC3 studies
WTCCC3 studies
Anorexia Nervosa Host control of HIV-1 Renal Transplant Dysfunction Pre-Eclampsia Primary Biliary Cirrhosis
Press & publications
Press Release: 28/09/2005 Press Release: 06/06/2007 Publications and presentations
Data access
Access to data Approved Applications CDAC members Data formats FAQ
Open access
Available software
Participant access
Participant Login
Contact
Feedback and queries

Primary Biliary Cirrhosis

Dr Richard Sandford

George Mells, Heather Cordell, David EJ Jones, James Neuberger, Graeme JM Alexander, Michael Heneghan, Peter T Donaldson.

Primary biliary cirrhosis (PBC) is a chronic liver disease that affects over 1 in 5000 people in the UK. It usually affects middle-aged or older women. There is no known cure and many patients eventually develop cirrhosis and liver failure, for which the only treatment is liver transplantation. PBC is thought to be a complex disease, meaning that it is caused by a combination of genetic and environmental factors. There is good evidence that genetic factors are important. For example, relatives of a person with PBC are more likely to develop PBC than people in the general population. Large-scale genetic studies are required to identify the genes involved in causing PBC. These genetic studies called genome-wide association studies (GWAS) require DNA samples from at least 2000 individuals. Via the UK PBC Consortium these samples have been collected and will be used in collaboration with The Wellcome Trust to identify genetic variants associated and potentially causal for PBC. This will form the basis of future clinical and drug studies in PBC patients.